Company QUANTUM GENOMICS Euronext Paris
Equities
FR0011648971
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Business Summary
All sales are abroad.
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Medicines
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -98.34% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -98.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | - | |
Lionel Ségard
FOU | Founder | 56 | 23/05/23 |
Benoît Gueugnon
DFI | Director of Finance/CFO | - | 01/18/01 |
Bruno Besse
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Chief Tech/Sci/R&D Officer | - | - | |
General Counsel | - | 04/22/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lionel Ségard
FOU | Founder | 56 | 23/05/23 |
François Pelen
BRD | Director/Board Member | 67 | - |
Chief Executive Officer | 63 | - | |
Director/Board Member | 58 | - | |
François Durvye
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 34,854,981 | 30,403,091 ( 87.23 %) | 0 | 87.23 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ALQGC Stock
- Stock
- Company QUANTUM GENOMICS